Study of GemOx and Vandetanib in Advanced Solid Malignancy

NCT00660725 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Advanced Incurable Solid Malignancy

Interventions

DRUG: Vandetanib
DRUG: Gemcitabine
DRUG: Oxaliplatin

Sponsor

Leonard Appleman

Collaborators

[object Object]